Effect of radium-223 dichloride on symptomatic skeletal events in patients with castration-resistant prostate cancer and bone metastases: results from a phase 3, double-blind, randomised trial
2014 ◽
Vol 15
(7)
◽
pp. 738-746
◽
Keyword(s):
Phase 3
◽